In Harrington v Purdue Pharma,1 the United States Supreme Court held that so-called “non-consensual third-party releases” were not permitted in restructuring plans proposed under Chapter 11 of the US Bankruptcy Code. A “third-party release” arises where creditors are asked to vote on a restructuring plan or scheme which not only proposes to release the debtor company (i.e. the company that has petitioned for bankruptcy or is proposing the scheme) from all liability but to also release other third parties from any associated liability.
Ireland, United Kingdom, USA, Insolvency & Restructuring, Litigation, McCann FitzGerald LLP, Companies Act 2006 (UK), Insolvency Regulation (1346/2000) (EU), Supreme Court of the United States, Pharmaceuticals